Literature DB >> 2310733

Orbital recurrence of retinoblastoma successfully treated by combined therapy.

R R Goble1, J McKenzie, J E Kingston, P N Plowman, J L Hungerford.   

Abstract

Five children with an orbital recurrence of retinoblastoma have been successfully treated by a combination of excision biopsy of the tumour mass, radical orbital radiotherapy, and systemic chemotherapy. Nine previous children, consecutive with the five presented here, died from disseminated retinoblastoma after failure of earlier treatment programmes for orbital recurrence. An aggressive therapeutic approach is justified by this improvement in survival.

Entities:  

Mesh:

Year:  1990        PMID: 2310733      PMCID: PMC1041999          DOI: 10.1136/bjo.74.2.97

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

Review 1.  Chemotherapy for retinoblastoma: a current topic.

Authors:  P T Finger; G Czechonska; H Demirci; A Rausen
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

Review 2.  Current management strategies for intraocular retinoblastoma.

Authors:  Jonathan W Kim; David H Abramson; Ira J Dunkel
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Orbital retinoblastoma: Present status and future challenges - A review.

Authors:  Mohammad J Ali; Santosh G Honavar; Vijay A P Reddy
Journal:  Saudi J Ophthalmol       Date:  2010-10-13

4.  Cytopathological Evaluation of Ocular Surface and Needle Washings Following Intravitreal Melphalan Injections for Retinoblastoma.

Authors:  Jasmine H Francis; Ijah Mondesire-Crump; Brian P Marr; Scott E Brodie; David H Abramson
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2016-02-04       Impact factor: 1.402

Review 5.  Retinoblastoma: achieving new standards with methods of chemotherapy.

Authors:  Swathi Kaliki; Carol L Shields
Journal:  Indian J Ophthalmol       Date:  2015-02       Impact factor: 1.848

Review 6.  Orbital retinoblastoma: An update.

Authors:  Santosh G Honavar; Fairooz P Manjandavida; Vijay Anand P Reddy
Journal:  Indian J Ophthalmol       Date:  2017-06       Impact factor: 1.848

7.  Orbital relapse of retinoblastoma in patients with high-risk histopathology features.

Authors:  Maria Vittoria Cicinelli; Swathi Kaliki
Journal:  Ther Adv Ophthalmol       Date:  2019-04-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.